{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:51:38Z","timestamp":1790200298907,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAPES-Cofecub"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001852","name":"CEFIPRA","doi-asserted-by":"publisher","award":["4803-04"],"award-info":[{"award-number":["4803-04"]}],"id":[{"id":"10.13039\/501100001852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.exppara.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T02:23:53Z","timestamp":1533090233000},"page":"85-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion"],"prefix":"10.1016","volume":"192","author":[{"given":"Andreza","family":"Rochelle do Vale Morais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Leandro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Cojean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaluvu","family":"Balaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0575-4544","authenticated-orcid":false,"given":"Christian","family":"Bories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-3991","authenticated-orcid":false,"given":"Eryvaldo S\u00f3crates Tabosa","family":"do Egito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe M.","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2018.07.017_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejmech.2012.03.003","article-title":"Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives","volume":"52","author":"Audisio","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2018.07.017_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mycmed.2012.10.003","article-title":"New strategy for enhancing the therapeutic index of Fungizone((R))","volume":"23","author":"Belkherroubi-Sari","year":"2013","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.exppara.2018.07.017_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.colsurfb.2014.01.014","article-title":"Amphotericin B topical microemulsion: formulation, characterization and evaluation","volume":"116","author":"Butani","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.exppara.2018.07.017_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejps.2015.01.015","article-title":"Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis","volume":"70","author":"Caldeira","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.exppara.2018.07.017_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.11.023","article-title":"A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis","volume":"416","author":"Chattopadhyay","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exppara.2018.07.017_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/jac\/dkg455","article-title":"Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774","volume":"52","author":"Cheron","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.48.3.1047-1050.2004","article-title":"Comparative efficacies of four amphotericin B formulations - fungizone, amphotec (Amphocil), AmBisome, and Abelcet - against systemic murine aspergillosis","volume":"48","author":"Clemons","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib8","first-page":"141","article-title":"How can micelle systems be rebuilt by a heating process?","volume":"7","author":"da Silva","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2018.07.017_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1166\/jbn.2012.1374","article-title":"Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product","volume":"8","author":"Damasceno","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2018.07.017_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1208\/s12249-007-9022-8","article-title":"Formulation and evaluation of microemulsion based delivery system for amphotericin B","volume":"9","author":"Darole","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.exppara.2018.07.017_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2008.01.004","article-title":"Parenteral microemulsions: an overview","volume":"355","author":"Date","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib12","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.07.017_bib13","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/AAC.02398-12","article-title":"Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay","volume":"57","author":"De Rycker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-3156.2004.01296.x","article-title":"Anti-leishmanial activity of a new formulation of amphotericin B","volume":"9","author":"Dea-Ayuela","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2018.07.017_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/38.3.485","article-title":"In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system","volume":"38","author":"Egito","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(96)04713-8","article-title":"A morphological study of an amphotericin B emulsion-based delivery system","volume":"145","author":"Egito","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib17","first-page":"155","article-title":"New techniques for preparing submicron emulsions - application to amphotericin B","volume":"4","author":"Egito","year":"1994","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.exppara.2018.07.017_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.05.013","article-title":"Effect of aggregation state on the toxicity of different amphotericin B preparations","volume":"361","author":"Espada","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: a review","volume":"12","author":"Fanos","year":"2000","journal-title":"J. Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1166\/jbn.2012.1435","article-title":"Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association","volume":"8","author":"Franzini","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2018.07.017_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12551-013-0134-y","article-title":"Antimony transport mechanisms in resistant leishmania parasites","volume":"6","author":"Fr\u00e9zard","year":"2014","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.exppara.2018.07.017_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-4622(96)02241-7","article-title":"Physico-chemical properties of the heat-induced \u2018superaggregates\u2019 of amphotericin B","volume":"66","author":"Gaboriau","year":"1997","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.exppara.2018.07.017_bib23","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.41.11.2345","article-title":"Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index","volume":"41","author":"Gaboriau","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1590\/0037-8682-0198-2013","article-title":"Biochemical and nutritional evaluation of patients with visceral leishmaniasis before and after treatment with leishmanicidal drugs","volume":"46","author":"Gatto","year":"2013","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.exppara.2018.07.017_bib25","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2165\/00003495-200464170-00004","article-title":"Amphotericin B lipid complex","volume":"64","author":"Goldsmith","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.exppara.2018.07.017_bib26","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1111\/bph.13149","article-title":"Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified Carrier for oral delivery: an approach for non-toxic chemotherapy","volume":"172","author":"Gupta","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exppara.2018.07.017_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.exppara.2018.07.017_bib28","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0006-3495(02)75326-5","article-title":"ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy","volume":"83","author":"Huang","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.exppara.2018.07.017_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2011.01.044","article-title":"Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin B","volume":"408","author":"Iman","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1208\/s12249-010-9440-x","article-title":"Formulation development of parenteral phospholipid-based microemulsion of etoposide","volume":"11","author":"Jain","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.exppara.2018.07.017_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/10837450701555885","article-title":"SolEmuls\u00ae technology: a way to overcome the drawback of parenteral administration of insoluble drugs","volume":"12","author":"Junghanns","year":"2007","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.exppara.2018.07.017_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/10611861003649712","article-title":"A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel","volume":"18","author":"Kang","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.exppara.2018.07.017_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New world and old world leishmania infections: a practical review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.exppara.2018.07.017_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbamem.2004.05.003","article-title":"New lipid formulation of amphotericin B: spectral and microscopic analysis","volume":"1664","author":"Larabi","year":"2004","journal-title":"BBA. Biomembranes"},{"key":"10.1016\/j.exppara.2018.07.017_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exppara.2018.07.017_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijpharm.2003.10.031","article-title":"Stability and transdermal absorption of topical amphotericin B liposome formulations","volume":"270","author":"Manosroi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"Mbongo","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib38","first-page":"767","article-title":"Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model","volume":"137","author":"Mishra","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.exppara.2018.07.017_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.actatropica.2015.12.016","article-title":"Visceral leishmaniasis: revisiting current treatments and approaches for future discoveries","volume":"155","author":"No","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2018.07.017_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.colsurfb.2008.06.016","article-title":"Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B","volume":"66","author":"Pestana","year":"2008","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.exppara.2018.07.017_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jac\/42.6.779","article-title":"In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating","volume":"42","author":"Petit","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.43.2.390","article-title":"Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani","volume":"43","author":"Petit","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biochi.2014.06.007","article-title":"Development of antileishmanial lipid nanocomplexes","volume":"107","author":"Pham","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.exppara.2018.07.017_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.07.017_bib45","first-page":"189","article-title":"Solubility of amphotericin B in water-lecithin-dispersions and lecithin-based submicron emulsions","volume":"26","author":"Salerno","year":"2013","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.exppara.2018.07.017_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2875-10-85","article-title":"Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity","volume":"10","author":"Sarr","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.exppara.2018.07.017_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ijpharm.2013.05.044","article-title":"Development of oil-in-water microemulsions for the oral delivery of amphotericin B","volume":"454","author":"Silva","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.07.017_bib48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/1570159X14666151109110734","article-title":"Development and characterization of a microemulsion system containing amphotericin B with potential ocular applications","volume":"13","author":"Silveira","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.exppara.2018.07.017_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/08982104.2011.584317","article-title":"Investigations on feasibility of in situ development of amphotericin B liposomes for industrial applications","volume":"22","author":"Singodia","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.exppara.2018.07.017_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1208\/s12249-014-0085-z","article-title":"Influence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systems","volume":"15","author":"Siqueira","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.exppara.2018.07.017_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.msec.2014.11.069","article-title":"Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility","volume":"48","author":"Skiba-Lahiani","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.exppara.2018.07.017_bib52","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1021\/jp510245n","article-title":"Self-association of amphotericin B: spontaneous formation of molecular structures responsible for the toxic side effects of the antibiotic","volume":"118","author":"Starzyk","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.exppara.2018.07.017_bib53","series-title":"Host Resistance to the Khartoum Strain of Leishmania Donovani","first-page":"80","author":"Stauber","year":"1958"},{"key":"10.1016\/j.exppara.2018.07.017_bib54","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/la7008573","article-title":"Fluorescence of amphotericin B-deoxycholate (fungizone) monomers and aggregates and the effect of heat-treatment","volume":"23","author":"Stoodley","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.exppara.2018.07.017_bib55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.biopha.2008.09.002","article-title":"Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials","volume":"62","author":"Vieira","year":"2008","journal-title":"Biomed. Pharmacother."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941830136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941830136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:15:53Z","timestamp":1604718953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448941830136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":55,"alternative-id":["S001448941830136X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2018.07.017","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}